SCOPE FLUIDICS SA ZY-10 (S84) - Total Liabilities
Based on the latest financial reports, SCOPE FLUIDICS SA ZY-10 (S84) has total liabilities worth €33.50 Million EUR (≈ $39.17 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of SCOPE FLUIDICS SA ZY-10 to evaluate the company's liquid asset resilience ratio.
SCOPE FLUIDICS SA ZY-10 - Total Liabilities Trend (2021–2025)
This chart illustrates how SCOPE FLUIDICS SA ZY-10's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is SCOPE FLUIDICS SA ZY-10's balance sheet.
SCOPE FLUIDICS SA ZY-10 Competitors by Total Liabilities
The table below lists competitors of SCOPE FLUIDICS SA ZY-10 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Lakeshore Acquisition III Corp. Ordinary Shares
NASDAQ:LCCC
|
USA | $2.42 Million |
|
Negri Sembilan Oil Palms Bhd
KLSE:2038
|
Malaysia | RM87.67 Million |
|
Tainergy Tech Co Ltd
TW:4934
|
Taiwan | NT$640.67 Million |
|
Tsang Yow Industrial Co Ltd
TW:1568
|
Taiwan | NT$353.63 Million |
|
Papoutsanis S.A
AT:PAP
|
Greece | €47.64 Million |
|
Yuhwa Sec
KO:003460
|
Korea | ₩437.48 Billion |
|
Shinsegae Food
KO:031440
|
Korea | ₩445.57 Billion |
|
Phoenix Group Holdings PLC
LSE:PHNX
|
UK | GBX331.44 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down SCOPE FLUIDICS SA ZY-10's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See S84 net asset quality score to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 13.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SCOPE FLUIDICS SA ZY-10's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SCOPE FLUIDICS SA ZY-10 (2021–2025)
The table below shows the annual total liabilities of SCOPE FLUIDICS SA ZY-10 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €33.50 Million ≈ $39.17 Million |
+26.34% |
| 2024-12-31 | €26.52 Million ≈ $31.00 Million |
+28.99% |
| 2023-12-31 | €20.56 Million ≈ $24.04 Million |
+55.96% |
| 2022-12-31 | €13.18 Million ≈ $15.41 Million |
-71.34% |
| 2021-12-31 | €45.99 Million ≈ $53.77 Million |
-- |
About SCOPE FLUIDICS SA ZY-10
Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. The company offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is based in Warsaw, Poland.